# IPRIVASK
> **BLA021271** · Biologics License Application · Sponsor: BAUSCH · Approved 2003-04-04
## Drug
- **FDA Application Number:** BLA021271
- **Application type:** Biologics License Application
- **Brand name:** IPRIVASK
- **Generic name:** Desirudin Recombinant
- **Active ingredients:** DESIRUDIN RECOMBINANT
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** BAUSCH
- **First approval:** 2003-04-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021271)
---
*AI Analytics · CC0 1.0*